DNA Transformation of Leishmania infantum Axenic Amastigotes and Their Use in Drug Screening

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2001-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.45.4.1168-1173.2001PMID 11257031PMCID PMC90440
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Leishmania resistant to sodium stibogluconate: drug-associated macrophage-dependent killing

  2004cited by this paper
• Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum.

  2000cited by this paper
• Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models.

  2000influential reference
• Targeted integration into a rRNA locus results in uniform and high level expression of transgenes in Leishmania amastigotes.

  2000cited by this paper
• Leishmaniasis.

  1999cited by this paper
• Stage-Specific Activity of Pentavalent Antimony against Leishmania donovani Axenic Amastigotes

  1999cited by this paper
• Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.

  1999cited by this paper
• Isolation of Genes Mediating Resistance to Inhibitors of Nucleoside and Ergosterol Metabolism in Leishmania by Overexpression/Selection*

  1999cited by this paper
• Increased transport of pteridines compensates for mutations in the high affinity folate transporter and contributes to methotrexate resistance in the protozoan parasite Leishmania tarentolae

  1999cited by this paper
• Genetic manipulation of kinetoplastida.

  1999cited by this paper
• Cloning of Leishmania nucleoside transporter genes by rescue of a transport-deficient mutant.

  1998cited by this paper
• Axenically Grown Amastigotes of Leishmania infantum Used as an In Vitro Model To Investigate the Pentavalent Antimony Mode of Action

  1998influential reference
• Green Fluorescent Protein Reporter Microplate Assay for High-Throughput Screening of Compounds againstMycobacterium tuberculosis

  1998cited by this paper
• ABC transporters in Leishmania and their role in drug resistance.

  1998cited by this paper
• Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents

  1997influential reference
• Leishmania and human immunodeficiency virus coinfection: the first 10 years

  1997cited by this paper
• In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis

  1997cited by this paper
• An axenic amastigote system for drug screening

  1997cited by this paper
• Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes

  1997cited by this paper
• Use of Toxoplasma gondii expressing beta-galactosidase for colorimetric assessment of drug activity in vitro

  1997cited by this paper
• Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase

  1996cited by this paper
• The promoter for the ribosomal RNA genes of Leishmania chagasi.

  1996cited by this paper
• Drug cytotoxicity assay for African trypanosomes and Leishmania species.

  1995cited by this paper
• DNA-mediated transformation of bloodstream-form Trypanosoma brucei.

  1993cited by this paper
• Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages.

  1993cited by this paper
• Antileishmanial activity of sodium stibogluconate fractions

  1993cited by this paper
• Shuttle cosmid vectors for the trypanosomatid parasite Leishmania.

  1993influential reference
• An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1.

  1992influential reference
• Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.

  1992cited by this paper
• Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy.

  1990cited by this paper
• Stable expression of the bacterial neo r gene in Leishmania enriettii

  1990cited by this paper
• Semiautomated assessment of in vitro activity of potential antileishmanial drugs

  1985cited by this paper
• Activity of antileishmanial agents against amastigotes in human monocyte-derived macrophages and in mouse peritoneal macrophages.

  1984cited by this paper
• Leishmania mexicana: drug sensitivities of promastigotes and transforming amastigotes.

  1983cited by this paper
• An in vitro model for investigation of chemotherapeutic agents in leishmaniasis.

  1980cited by this paper

• Exploring hydrophilic 2,2-di(indol-3-yl)ethanamine derivatives against Leishmania infantum

  2024cites this paper
• Studies of the FBT family transporters in Leishmania infantum by gene deletion and protein localization.

  2024cites this paper
• Review on the Drug Intolerance and Vaccine Development for the Leishmaniasis.

  2023cites this paper
• A Simple Bioluminescent Assay for the Screening of Cytotoxic Molecules Against the Intracellular Form of Leishmania infantum.

  2022cites this paper
• Imaging Infection by Vector-Borne Protozoan Parasites Using Whole-Mouse Bioluminescence.

  2022cites this paper
• Reporter gene systems: A powerful tool for Leishmania studies

  2022cites this paper
• Thiophene derivatives activity against the protozoan parasite Leishmania infantum

  2022cites this paper
• Toward Chemical Validation of Leishmania infantum Ribose 5-Phosphate Isomerase as a Drug Target

  2021cites this paper
• Synthesis, Characterization, and Antileishmanial Activity of Neutral Gold(I) Complexes with N-heterocyclic Carbene Ligands Bearing Sulfur-Containing Side Arms

  2021cites this paper
• Well-Tolerated Amphotericin B Derivatives That Effectively Treat Visceral Leishmaniasis.

  2021cites this paper
• Murine infection with bioluminescent Leishmania infantum axenic amastigotes applied to drug discovery

  2019cites this paper
• Quantification of Leishmania Parasites in Murine Models of Visceral Infection.

  2019cites this paper
• Valosin‐containing protein VCP/p97 is essential for the intracellular development of Leishmania and its survival under heat stress

  2018cites this paper
• Caracterización de una nueva diana farmacológica en Leishmania spp. e identificación de compuestos activos frente a Trypanosoma brucei

  2018cites this paper
• Synthesis, characterization, and antileishmanial activity of neutral N-heterocyclic carbenes gold(I) complexes.

  2018cites this paper
• Whole-mouse in vivo bioluminescence imaging applied to drug screening against Leishmania infantum: a reliable method to evaluate efficacy and optimize treatment regimens

  2018cites this paper
• Chemotherapy and Experimental Models of Visceral Leishmaniasis

  2018cites this paper
• Synthesis of aminophenylhydroxamate and aminobenzylhydroxamate derivatives and in vitro screening for antiparasitic and histone deacetylase inhibitory activity

  2018cites this paper
• In vivo imaging of pathogen homing to the host tissues.

  2017cites this paper
• Development of Phenotypic Drug Discovery Models for Tropical Parasitic Diseases

  2017cites this paper
• Biological activities of triterpenoids from Poraqueiba sericea stems

  2017cites this paper
• Leishmania antimony resistance/ susceptibility in Algerian foci

  2017cites this paper
• Recent advances in Leishmania reverse genetics: Manipulating a manipulative parasite.

  2017cites this paper
• The Pumilio-domain protein PUF6 contributes to SIDER2 retroposon-mediated mRNA decay in Leishmania

  2017cites this paper
• Mechanistic insights of SIDER2 retroposon-mediated mRNA decay in Leishmania

  2017cites this paper
• RNA secondary structure and nucleotide composition of the conserved hallmark sequence of Leishmania SIDER2 retroposons are essential for endonucleolytic cleavage and mRNA degradation

  2017cites this paper
• A non-commercial approach for the generation of transgenic Leishmania tarentolae and its application in antileishmanial drug discovery

  2016cites this paper
• Etude de la chimiorésastance aux antimoniés chez leishmania en Algerie : Validation des tests in vitro et développement de marqueurs moléculaires

  2016cites this paper
• DDX3 DEAD-box RNA helicase plays a central role in mitochondrial protein quality control in Leishmania

  2016cites this paper
• Using Proteomics to Understand How Leishmania Parasites Survive inside the Host and Establish Infection

  2016cites this paper
• A Telomeric Cluster of Antimony Resistance Genes on Chromosome 34 of Leishmania infantum

  2016cites this paper
• The unique Leishmania EIF4E4 N-terminus is a target for multiple phosphorylation events and participates in critical interactions required for translation initiation

  2015cites this paper
• Trypanosomatids see the light: recent advances in bioimaging research.

  2015cites this paper
• In Vitro Infectivity Assessment by Drug Susceptibility Comparison of Recombinant Leishmania major Expressing Enhanced Green Fluorescent Protein or EGFP-Luciferase Fused Genes with Wild-Type Parasite

  2015cites this paper
• Etude phytochimique et biologique de cinq espèces de la flore péruvienne. Evaluation de leurs propriétés antileishmanienne et cytotoxique

  2015cites this paper
• Desenvolvimento de estratégias alternativas para teste de fármacos: obtenção e caracterização de linhagens mutantes estáveis de Leishmania expressando luciferase

  2014cites this paper
• Leishmanioses do continente americano

  2014cites this paper
• Phenotypic and Genotypic Analysis of in vitro Selected Miltefosine Resistant Leishmania donovani

  2013cites this paper
• Retrospective and ongoing researches on Leishmania antimony resistance in Algeria

  2013cites this paper
• Evaluating and exploiting the function of a Leishmania major type I nitroreductase in the development of novel leishmanicidal prodrugs.

  2013cites this paper
• Luminescent multiplex viability assay for Trypanosoma brucei gambiense

  2013cites this paper
• Antibacterial and leishmanicidal activities of temporin-SHd, a 17-residue long membrane-damaging peptide.

  2013cites this paper
• Parasite burden in Leishmania (Leishmania) amazonensis-infected mice: validation of luciferase as a quantitative tool.

  2013cites this paper
• Genetic Polymorphisms and Drug Susceptibility in Four Isolates of Leishmania tropica Obtained from Canadian Soldiers Returning from Afghanistan

  2012cites this paper
• Novel Features of a PIWI-Like Protein Homolog in the Parasitic Protozoan Leishmania

  2012cites this paper
• Apoptosis-like programmed cell death induces antisense ribosomal RNA (rRNA) fragmentation and rRNA degradation in Leishmania

  2012cites this paper
• Antibacterial, antifungal and antileishmanial activities of indolone-N-oxide derivatives

  2012cites this paper
• Appraisal of a Leishmania major Strain Stably Expressing mCherry Fluorescent Protein for Both In Vitro and In Vivo Studies of Potential Drugs and Vaccine against Cutaneous Leishmaniasis

  2012cites this paper
• Development of Luciferase Expressing Leishmania donovani Axenic Amastigotes as Primary Model for In Vitro Screening of Antileishmanial Compounds

  2012cites this paper
• Comparação da heterogeneidade genética e da sensibilidade in vitro ao antimoniato de meglumina entre amostras de Leishmania braziliensis isoladas de pacientes Respondedores e Não Respondedores ao tratamento da leishmaniose cutânea

  2012cites this paper
• Improvement of the green fluorescent protein reporter system in Leishmania spp. for the in vitro and in vivo screening of antileishmanial drugs.

  2012cites this paper
• In vitro activity of nicotinamide/antileishmanial drug combinations.

  2011cites this paper
• Use of In Vivo and In Vitro Systems to Select Leishmania amazonensis Expressing Green Fluorescent Protein

  2011influential citation
• Luciferase-Expressing Leishmania infantum Allows the Monitoring of Amastigote Population Size, In Vivo, Ex Vivo and In Vitro

  2011cites this paper
• Visceral leishmaniasis: Experimental models for drug discovery

  2011cites this paper
• Promastigote to amastigote differentiation of Leishmania is markedly delayed in the absence of PERK eIF2alpha kinase‐dependent eIF2alpha phosphorylation

  2011cites this paper
• Induction of a Peptide with Activity against a Broad Spectrum of Pathogens in the Aedes aegypti Salivary Gland, following Infection with Dengue Virus

  2011cites this paper
• Antimony speciation analysis HPLC methods with ICP

  2011cites this paper
• Reduction of Sb(V) in a Human Macrophage Cell Line Measured by HPLC-ICP-MS

  2011cites this paper
• Susceptibility Test Methods: Parasites

  2011cites this paper
• Antileishmanial Drugs: search for t SIR2 inhibitors

  2011influential citation
• Selective inactivation of SIDER2 retroposon‐mediated mRNA decay contributes to stage‐ and species‐specific gene expression in Leishmania

  2010influential citation
• Characterization of the leishmanicidal activity of antimicrobial peptides.

  2010cites this paper
• Proteomics of trypanosomatids of human medical importance.

  2010cites this paper
• Bisnaphthalimidopropyl Derivatives as Inhibitors of Leishmania SIR2 Related Protein 1

  2010cites this paper
• Stage-specific expression of the glycine cleavage complex subunits in Leishmania infantum.

  2010cites this paper
• An Experimental Approach for the Identification of Conserved Secreted Proteins in Trypanosomatids

  2010cites this paper
• Down regulation of KMP-11 in Leishmania infantum axenic antimony resistant amastigotes as revealed by a proteomic screen.

  2009cites this paper
• The γ‐glutamylcysteine synthetase gene of Leishmania is essential and involved in response to oxidants

  2009cites this paper
• Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening.

  2009cites this paper
• Supporting Information to : Anti-leishmanial Lindenane Sesquiterpenes from Hedyosmum angustifolium

  2009cites this paper
• Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.

  2009cites this paper
• Leishmania (Viannia) panamensis: an in vitro assay using the expression of GFP for screening of antileishmanial drug.

  2009cites this paper
• The role of reduced pterins in resistance to reactive oxygen and nitrogen intermediates in the protozoan parasite Leishmania.

  2009cites this paper
• Reporter genes facilitating discovery of drugs targeting protozoan parasites.

  2009influential citation
• Recognition of Leishmania Parasites by Innate Immunity

  2009cites this paper
• Characterization of a new large family of extinct short retroposons in the protozoan parasite Leishmania and their role in post-transcriptional regulation of gene expression

  2009influential citation
• Differential gene expression studies to explore the molecular mechanism of drug resistance in Leishmania donovani field isolates

  2009cites this paper
• Anti-Leishmanial Lindenane Sesquiterpenes from Hedyosmum angustifolium

  2009cites this paper
• Transgenic Leishmania and the immune response to infection

  2008cites this paper
• Genome-wide gene expression profiling analysis of Leishmania major and Leishmania infantum developmental stages reveals substantial differences between the two species

  2008cites this paper
• Isolation, characterization and molecular cloning of new temporins from the skin of the North African ranid Pelophylax saharica.

  2008cites this paper
• A protein of the leucine-rich repeats (LRRs) superfamily is implicated in antimony resistance in Leishmania infantum amastigotes.

  2008cites this paper
• Studies on oligopeptidase B of Leishmania major

  2008influential citation
• Estudos da cinética do antimônio e alterações de ci tocromos P450 hepáticos em primatas e ratos tratados com antimoniato de meglumina

  2008cites this paper
• Modulation of Gene Expression in Human Macrophages Treated with the Anti- Leishmania Pentavalent Antimonial Drug Sodium Stibogluconate (cid:1) †

  2008cites this paper
• A Proteomics Screen Implicates HSP83 and a Small Kinetoplastid Calpain-related Protein in Drug Resistance in Leishmania donovani Clinical Field Isolates by Modulating Drug-induced Programmed Cell Death*

  2007cites this paper
• La leishmania spp. como estrategia de Diagnóstico y tratamiento de la leishmaniasis, un artículo de revisión

  2007cites this paper
• Targeting of antileishmanial drugs produced by nanotechnologies

  2007cites this paper
• Role of the ABC Transporter PRP1 (ABCC7) in Pentamidine Resistance in Leishmania Amastigotes

  2007cites this paper
• Modulation of Gene Expression in Human Macrophages Treated with the Anti-Leishmania Pentavalent Antimonial Drug Sodium Stibogluconate

  2007influential citation
• Papel do transportador ABC PRP1 na resistência à pentamidina em Leishmania spp.

  2007cites this paper
• Advances and perspectives in Leishmania cell based drug-screening procedures.

  2007cites this paper
• Proof of interaction between Leishmania SIR2RP1 deacetylase and chaperone HSP83

  2007cites this paper
• Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs

  2007cites this paper
• Modulation of Leishmania ABC Protein Gene Expression through Life Stages and among Drug-Resistant Parasites

  2006cites this paper
• A new library of C-16 modified artemisinin analogs and evaluation of their anti-parasitic activities.

  2006cites this paper
• Leishmania amastigotes as targets for drug screening

  2006cites this paper
• Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica Parasites

  2006influential citation
• Leishmania cytosolic silent information regulatory protein 2 deacetylase induces murine B‐cell differentiation and in vivo production of specific antibodies

  2006cites this paper